Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement.

PubWeight™: 2.93‹?› | Rank: Top 1%

🔗 View Article (PMC 1697808)

Published in Health Res Policy Syst on December 05, 2006

Authors

Holger J Schünemann1, Atle Fretheim, Andrew D Oxman

Author Affiliations

1: INFORMA/CLARITY Research Group, S,C, Epidemiologia, Istitituto Regina Elena, Via Elio Chianesi 53, 00144 Rome, Italy. hjs@buffalo.edu

Articles citing this

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak (2008) 5.28

Evidence-based clinical guidelines for immigrants and refugees. CMAJ (2010) 3.57

SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.45

Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31

Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. Health Res Policy Syst (2006) 2.29

Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst (2006) 2.24

Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst (2006) 2.15

Improving the use of research evidence in guideline development: 5. Group processes. Health Res Policy Syst (2006) 1.87

Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ (2013) 1.86

Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80

Perceived barriers to guideline adherence: a survey among general practitioners. BMC Fam Pract (2011) 1.53

Differences among international pharyngitis guidelines: not just academic. Ann Fam Med (2007) 1.49

Reconsidering patient participation in guideline development. Health Care Anal (2008) 1.47

Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations. Implement Sci (2012) 1.34

Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Policy Syst (2006) 1.27

How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implement Sci (2010) 1.24

Values associated with public involvement in health and social care research: a narrative review. Health Expect (2013) 1.23

Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res (2012) 1.14

Insights about the process and impact of implementing nursing guidelines on delivery of care in hospitals and community settings. BMC Health Serv Res (2008) 1.12

How well do guidelines incorporate evidence on patient preferences? J Gen Intern Med (2009) 1.08

Development of guidelines for recently arrived immigrants and refugees to Canada: Delphi consensus on selecting preventable and treatable conditions. CMAJ (2010) 1.06

The "Child Health Evidence Week" and GRADE grid may aid transparency in the deliberative process of guideline development. J Clin Epidemiol (2012) 1.05

Implementing clinical practice guidelines about health promotion and disease prevention through shared decision making. J Gen Intern Med (2013) 1.03

Comparison of international guideline programs to evaluate and update the Dutch program for clinical guideline development in physical therapy. BMC Health Serv Res (2007) 0.99

Perspectives on the role of stakeholders in knowledge translation in health policy development in Uganda. BMC Health Serv Res (2013) 0.91

Do guidelines influence the implementation of health programs?--Uganda's experience. Implement Sci (2012) 0.91

Consumer involvement in topic and outcome selection in the development of clinical practice guidelines. Health Expect (2011) 0.91

A knowledge synthesis of patient and public involvement in clinical practice guidelines: study protocol. Implement Sci (2009) 0.84

'Knowledge for better health' revisited - the increasing significance of health research systems: a review by departing Editors-in-Chief. Health Res Policy Syst (2017) 0.83

Shared decision making does not influence physicians against clinical practice guidelines. PLoS One (2013) 0.83

Patients, health information, and guidelines: A focus-group study. Scand J Prim Health Care (2015) 0.83

Addressing implementation challenges during guideline development - a case study of Swedish national guidelines for methods of preventing disease. BMC Health Serv Res (2015) 0.81

Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep (2012) 0.80

From evidence to action: Understanding clinical practice guidelines. Acta Orthop (2009) 0.79

Supporting a person-centred approach in clinical guidelines. A position paper of the Allied Health Community - Guidelines International Network (G-I-N). Health Expect (2013) 0.78

Framework for enhancing clinical practice guidelines through continuous patient engagement. Health Expect (2016) 0.78

The making of nursing practice law in Lebanon: a policy analysis case study. Health Res Policy Syst (2014) 0.78

Assessing policy dialogues and the role of context: Liberian case study before and during the Ebola outbreak. BMC Health Serv Res (2016) 0.77

[Pain assessment in elderly nursing home residents: methods paper for the S3-guideline development]. Schmerz (2012) 0.77

Evidence-based guidelines: Improving AGREEment on consistence evaluation. J Bone Oncol (2012) 0.75

Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes (2017) 0.75

Understanding optimal approaches to patient and caregiver engagement in the development of cancer practice guidelines: a mixed methods study. BMC Health Serv Res (2017) 0.75

The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines. Int J Neuropsychopharmacol (2016) 0.75

Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives. Adv Nutr (2017) 0.75

Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests. World J Surg (2017) 0.75

Engaging Patients and Caregivers Managing Rare Diseases to Improve the Methods of Clinical Guideline Development: A Research Protocol. JMIR Res Protoc (2017) 0.75

Articles cited by this

EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care (2003) 12.01

Systematic review of involving patients in the planning and development of health care. BMJ (2002) 10.70

National Institute for Clinical Excellence and its value judgments. BMJ (2004) 8.97

More informative abstracts of articles describing clinical practice guidelines. Ann Intern Med (1993) 6.54

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96

Health status: types of validity and the index of well-being. Health Serv Res (1976) 5.55

Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Cochrane Database Syst Rev (2006) 5.07

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ (2001) 4.66

Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess (2004) 4.59

Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess (2001) 4.31

Utilities and quality-adjusted life years. Int J Technol Assess Health Care (1989) 4.18

Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol (1998) 3.57

Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31

Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. Int J Qual Health Care (2003) 3.27

Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics (1995) 2.79

Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme. Qual Health Care (2001) 2.70

What does it mean to involve consumers successfully in NHS research? A consensus study. Health Expect (2004) 2.69

Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst (2006) 2.15

Involving consumers in a needs-led research programme: a pilot project. Health Expect (2001) 2.10

Dissemination of Evidence-based Practice Center reports. Ann Intern Med (2005) 2.05

Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80

Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care (2005) 1.80

Influence of clinicians' values and perceptions on use of clinical practice guidelines for sedation and neuromuscular blockade in patients receiving mechanical ventilation. Am J Crit Care (2000) 1.67

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med (1996) 1.66

Methodology for measuring health-state preferences--I: Measurement strategies. J Clin Epidemiol (1989) 1.54

Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity. Health Res Policy Syst (2006) 1.46

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004. Eur J Neurol (2004) 1.28

Improving the use of research evidence in guideline development: 6. Determining which outcomes are important. Health Res Policy Syst (2006) 1.27

Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol (2002) 1.25

Spine update. Patient preferences and the development of practice guidelines. Spine (Phila Pa 1976) (1998) 1.17

A meta-analysis demonstrates no significant differences between patient and population preferences. J Clin Epidemiol (2006) 1.12

Consumer involvement in the health technology assessment program. Int J Technol Assess Health Care (2004) 1.11

Are clinical practice guidelines impartial? Int J Technol Assess Health Care (2004) 1.00

Consumer collaboration, patient-defined outcomes and the preparation of Cochrane Reviews. Health Expect (1999) 0.98

Using practice guidelines to allocate medical technologies. An ethics framework. Int J Technol Assess Health Care (2000) 0.90

The progress of lay involvement in the NHS Research and Development Programme. J Eval Clin Pract (1996) 0.90

Treatment of stage IIIA non-small cell lung cancer. Chest (2003) 0.85

Methodology of guideline development. Neurosurgery (2002) 0.81

Articles by these authors

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev (2012) 10.32

GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02

Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86

Going from evidence to recommendations. BMJ (2008) 7.30

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20

Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2009) 7.07

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

Use of evidence in WHO recommendations. Lancet (2007) 6.12

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol (2010) 5.78

Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ (2009) 5.68

Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med (2007) 5.63

Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev (2009) 5.57

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10

SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst (2009) 3.93

Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ (2003) 3.92

The OFF theory of research utilization. J Clin Epidemiol (2005) 3.79

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65

GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol (2010) 3.60

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.45

GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44

SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.34

SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking? Health Res Policy Syst (2009) 3.32

Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31

GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet (2008) 3.28

GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02

A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci (2013) 3.00

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91

GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83

Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLoS Med (2006) 2.67

Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ (2002) 2.58

Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57

Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res (2005) 2.50

Paying for performance to improve the delivery of health interventions in low- and middle-income countries . Cochrane Database Syst Rev (2012) 2.49

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46

Summary-of-findings tables in Cochrane reviews improved understanding and rapid retrieval of key information. J Clin Epidemiol (2010) 2.34

Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence. Health Res Policy Syst (2006) 2.29

Conducting a meta-ethnography of qualitative literature: lessons learnt. BMC Med Res Methodol (2008) 2.28

Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care (2006) 2.27

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci (2013) 2.25

Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst (2006) 2.24

[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]. Tidsskr Nor Laegeforen (2002) 2.22

[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.20

[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.19

Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res (2012) 2.16

SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst (2009) 2.15

Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst (2006) 2.15

Evidence-informed health policy 1 - synthesis of findings from a multi-method study of organizations that support the use of research evidence. Implement Sci (2008) 2.15

HARLOT plc: an amalgamation of the world's two oldest professions. BMJ (2003) 2.14

User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews. J Clin Epidemiol (2010) 2.12

SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst (2009) 2.05

SUPPORT Tools for evidence-informed health Policymaking (STP) 10: Taking equity into consideration when assessing the findings of a systematic review. Health Res Policy Syst (2009) 2.03

SUPPORT tools for evidence-informed policymaking in health 6: Using research evidence to address how an option will be implemented. Health Res Policy Syst (2009) 2.02

SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst (2009) 2.00

SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst (2009) 1.99

Incorporating considerations of resources use into grading recommendations. BMJ (2008) 1.94

Evidence summaries tailored to health policy-makers in low- and middle-income countries. Bull World Health Organ (2010) 1.94

Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. SAHARA J (2008) 1.90

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90

Improving the use of research evidence in guideline development: 5. Group processes. Health Res Policy Syst (2006) 1.87

Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate. Cochrane Database Syst Rev (2008) 1.86

GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol (2012) 1.86

SUPPORT Tools for evidence-informed health Policymaking (STP) 8: Deciding how much confidence to place in a systematic review. Health Res Policy Syst (2009) 1.86

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85

The origins, evolution, and future of The Cochrane Database of Systematic Reviews. Int J Technol Assess Health Care (2009) 1.84

Medical messages in the media--barriers and solutions to improving medical journalism. Health Expect (2003) 1.84

SUPPORT Tools for evidence-informed health Policymaking (STP) 3: Setting priorities for supporting evidence-informed policymaking. Health Res Policy Syst (2009) 1.84

Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev (2011) 1.82

SUPPORT Tools for evidence-informed health Policymaking (STP) 5: Using research evidence to frame options to address a problem. Health Res Policy Syst (2009) 1.82

Using alternative statistical formats for presenting risks and risk reductions. Cochrane Database Syst Rev (2011) 1.81

SUPPORT tools for evidence-informed policymaking in health 18: Planning monitoring and evaluation of policies. Health Res Policy Syst (2009) 1.81

Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines. Health Res Policy Syst (2007) 1.81

Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80

Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Res Policy Syst (2006) 1.80

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol (2012) 1.75

Improving the use of research evidence in guideline development: 7. Deciding what evidence to include. Health Res Policy Syst (2006) 1.67

Improving the use of research evidence in guideline development: 2. Priority setting. Health Res Policy Syst (2006) 1.66